Developer docs
API playgroundTry for free, no card

Search company profiles

Aristopharma

Full company profile

uuid000fw3f

Namestring
Aristopharma
Legal namestring
Aristopharma Ltd
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Aristopharma Ltd is a privately held Bangladeshi pharmaceutical manufacturer founded in 1986 and headquartered in Dhaka. It is ranked among the top 10 pharmaceutical companies in Bangladesh and manufactures approximately 300–400 medicines across broad therapeutic categories including cardiovascular, anti-diabetic, ophthalmology, oncology, antibiotics, gastroenterology, respiratory, NSAIDs, and herbal products. The company serves patients in Bangladesh through a field sales force of approximately 3,000 medical representatives and a distribution network of 27 depots with ~1,200 distribution staff and cold-chain capability, and exports to 30+ countries across 5 continents. Its ophthalmic brand, Aristovision, has held the No. 1 position in the Bangladesh ophthalmic market continuously since 2006.

The company's production platform spans two manufacturing plants: the original Shampur, Dhaka facility (163,000 sq. ft.) and the Gachha, Gazipur facility (66,000 sq. ft., built 2010) built to UK MHRA standards with dedicated cephalosporin, ophthalmic, and oncology plants. Key imported technologies include Weiler (USA) Blow-Fill-Seal for preservative-free single-unit-dose ophthalmics, Glatt (Germany) fluid bed processing and auto-spray coating, and tri-layer tablet compression. Recent product launches span high-complexity biologics and biosimilars — Bevacizumab biosimilar (Bevaris), Rituximab (Rituris), Tirzepatide pre-filled syringe (Wikijet), and Resmetirom (Livheal) — alongside a 2022-launched Herbal Division. The ophthalmic facility received EU GMP approval in 2025, and the company operates under WHO cGMP across all plants.

Revenue is generated through one-time prescription pharmaceutical product sales to domestic and international distributors, healthcare providers, and patients; pricing is not publicly disclosed. The company is founder/management-controlled, led by Chairman & Managing Director M. A. Hassan, with no disclosed institutional investors, funding rounds, or M&A activity.

Short descriptiontext

Aristopharma Ltd is a privately held top-10 Bangladeshi pharmaceutical manufacturer founded in 1986, producing ~300 brands across cardiovascular, diabetes, ophthalmic, oncology, and herbal therapeutics for domestic patients and exports to 30+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersDhaka, Bangladesh
HQ citystring
Dhaka
HQ countrystring
Bangladesh
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, ophthalmic medicines, oncology therapeutics, cardio-diabetic formulations, biotech pharmaceuticals
Industry5 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Generic Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Manufacturing and selling quality medicines at affordable prices in Bangladesh and export markets. Products include pharmaceutical formulations across wide therapeutic classes including antiulcerants, antibiotics, NSAIDs, cardiovasculars, antidiabetics, steroids, and sophisticated products like Insulin, Inhalers, Anti-Cancer drugs, and biotech products.

aristopharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Aristovision
Description

Aristopharma's ophthalmic division that has completed its successful journey of 20 years in Bangladesh pharma market and has held the No. 1 position in the BD ophtha market since 2006.

aristopharma.com
Core offering1 text field

Aristopharma manufactures and sells approximately 300 pharmaceutical brands spanning multiple therapeutic classes including cardiovascular, antidiabetic, ophthalmic, oncology, gastroenterology, antibiotics, NSAIDs, respiratory, and herbal products. Operations are supported by two manufacturing plants in Bangladesh producing tablets, capsules, injectables, inhalers, ophthalmic solutions (including preservative-free single-unit dosages via Blow-Fill-Seal technology), lyophilized injections, pre-filled syringes, and biotech products such as Insulin and monoclonal antibodies (Bevacizumab, Rituximab).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • No.1 market position in Bangladesh ophthalmic market since 2006
+2 more records
Product overview1 text field

Aristopharma Ltd is a top 10 pharmaceutical company in Bangladesh manufacturing around 300 quality brands across diverse therapeutic classes. The portfolio includes cardiovascular products (Duoblock, Empaglif, Ivacard, Renvista, SabiCard), diabetes medications (Linaglip-M, Triflo, Wikijet, Wikitin), ophthalmic products (Optimox Eye Drop, Systear, Drylief, Taflan SUD, Cyporin DS, Cozopt SUD, Betaxol, Aristopin), gastroenterology medications (Rabe, Emep MUPS, Itopa-50, Vonofix, Sodipic), antibiotics (Afix, Lizox, Zavicef), oncology drugs (Bevaris, Rituris, Palbociclib), respiratory products (Asmalin Plus, Budison-FG, Montril, Docopa), orthopedic/pain management (Naburel, Joinflex-M, Adronic), and nutritional supplements (Fosibon-DK, Neobion, Tocogel, Cutin, Cozyten, Acufer, Ferijet). The company also has a dedicated herbal division and manufactures biotech products including insulin. Key manufacturing facilities include ophthalmic, cephalosporin, inhaler, lyophilized injection, and pre-filled syringe plants, with EU GMP approval for ophthalmic manufacturing.

Product and service6 records
1Pharma Products
CategoryPharma Products
Description

Wide range of branded generic pharmaceutical formulations including antiulcerants, antibiotics, NSAIDs, steroids, and other essential medicines manufactured at Aristopharma's plants in Shampur and Gachha, Gazipur. Targeted at physicians, hospitals, clinics, and pharmaceutical distributors in Bangladesh and 30+ export markets.

2Ophthalmic Products (Aristovision)
CategoryOphthalmic Pharmaceuticals
Description

Dedicated ophthalmic division Aristovision manufacturing ocular lubricants, anti-infective eye drops, anti-glaucoma preparations, steroid combinations, and preservative-free single-unit-dosage formulations using Blow-Fill-Seal technology. EU GMP certified facility. Has held the No. 1 position in Bangladesh's ophthalmic market since 2006. Products include Systear, Drylief, Taflan SUD, Cyporin DS, Cozopt SUD, Optimox, Betaxol, Aristopin, and Dexalev.

3Cardio-Diabetic Products
CategoryCardio-Diabetic Therapeutics
Description

Cardiovascular and antidiabetic branded formulations including SGLT2 inhibitors (Empaglif), DPP-4 inhibitors (Linaglip-M, Wikitin), dual GLP-1/GIP analogues (Wikijet), fixed-dose combinations (Duoblock, Temcard-A, Empaglif-M), sacubitril/valsartan (SabiCard), ivabradine (Ivacard), and resmetirom (Livheal) for NASH/MASH. Targeted at cardiologists, diabetologists, and endocrinology specialists.

4Oncology Products
CategoryOncology Biologics
Description

Anti-cancer biologics and chemotherapeutics including biosimilar monoclonal antibodies Bevacizumab (Bevaris) for various cancers, Rituximab (Rituris) for Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis, and zoledronic acid (Adronic 4) for osteoporosis. Manufactured in dedicated oncology plant within the Gachha, Gazipur campus.

5Herbal Products
CategoryHerbal / Nutraceutical Products
Description

Dedicated herbal product range manufactured at a WHO-cGMP compliant herbal plant within the Gazipur factory campus, including Fibosyl Powder, Arulina-500 (Spirulina), Hepamarin-140 (Silymarin), Joinflex-40, Anseng-500 (Panax ginseng), Ginkgo-B 60, and Primrole. Also encompasses Black Seed Oil (Blaksid) softgel and herbal cough formulations like Ivycof and Pepelif.

6Biotech Products
CategoryBiotech Pharmaceuticals
Description

Biopharmaceutical products including Insulin, monoclonal antibody biosimilars (Bevacizumab, Rituximab), and pre-filled syringe injectables manufactured at a dedicated biotech facility in the Gazipur plant. Targeted at hospitals, oncology centers, and patients requiring advanced biologic therapies.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the fastest-growing Bangladesh pharma manufacturers, focused on specialty generics, biotech, and export markets. Competes directly with Aristopharma in cardiology, oncology, and biotech.

TypeBroad incumbent
Description

Large Indian generic and specialty pharma player with global operations including biosimilars. Comparable therapeutic breadth and export footprint — relevant incumbent benchmark for Aristopharma's expansion ambitions.

TypeBroad incumbent
Description

Major Indian pharma with strong respiratory, oncology, and specialty portfolios and a sizable emerging-markets presence. Useful comparable for Aristopharma's inhaler/respiratory and specialty aspirations.

TypeDirect peer
Description

Bangladesh's largest pharmaceutical manufacturer. Same product categories (cardio, diabetic, oncology, ophthalmic, biotech), same domestic distribution dynamics, and similar export ambitions — the most direct comparable to Aristopharma.

5Sun Pharmaceutical Industries
TypeBroad incumbent
Description

India's largest specialty pharma company with a strong ophthalmology franchise. Closest large-cap analog to Aristopharma's specialty-generic and ophthalmic-led strategy.

TypeDirect peer
Description

Bangladesh pharma manufacturer with growing focus on specialty care, oncology, and biotech. Comparable in product mix and export ambitions to Aristopharma.

7Renata Limited
TypeDirect peer
Description

Bangladesh's leading animal health and specialty pharmaceutical company, with a strong domestic and emerging export footprint. Comparable in therapeutic breadth and Bangladesh market positioning.

8Beximco Pharmaceuticals
TypeDirect peer
Description

Top-3 Bangladesh pharma player with strong export presence and a broad specialty/generic portfolio, including biosimilars. Comparable in scale, therapeutic breadth, and export strategy to Aristopharma.

TypeDirect peer
Description

Diversified Bangladeshi conglomerate with a sizable pharma division spanning branded generics, specialty care, and biotech. Overlaps with Aristopharma across most therapeutic categories and competes in the same domestic market.

TypeDirect peer
Description

Bangladesh-based pharmaceutical company manufacturing generics and specialty products, including ophthalmics. Competes directly with Aristopharma in Bangladesh's domestic market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aristopharma

Generic Pharmaceuticalsaristopharma.com

Aristopharma Ltd is a privately held top-10 Bangladeshi pharmaceutical manufacturer founded in 1986, producing ~300 brands across cardiovascular, diabetes, ophthalmic, oncology, and herbal therapeutics for domestic patients and exports to 30+ countries.

What Aristopharma does

Aristopharma Ltd is a privately held Bangladeshi pharmaceutical manufacturer founded in 1986 and headquartered in Dhaka. It is ranked among the top 10 pharmaceutical companies in Bangladesh and manufactures approximately 300–400 medicines across broad therapeutic categories including cardiovascular, anti-diabetic, ophthalmology, oncology, antibiotics, gastroenterology, respiratory, NSAIDs, and herbal products. The company serves patients in Bangladesh through a field sales force of approximately 3,000 medical representatives and a distribution network of 27 depots with ~1,200 distribution staff and cold-chain capability, and exports to 30+ countries across 5 continents. Its ophthalmic brand, Aristovision, has held the No. 1 position in the Bangladesh ophthalmic market continuously since 2006.

The company's production platform spans two manufacturing plants: the original Shampur, Dhaka facility (163,000 sq. ft.) and the Gachha, Gazipur facility (66,000 sq. ft., built 2010) built to UK MHRA standards with dedicated cephalosporin, ophthalmic, and oncology plants. Key imported technologies include Weiler (USA) Blow-Fill-Seal for preservative-free single-unit-dose ophthalmics, Glatt (Germany) fluid bed processing and auto-spray coating, and tri-layer tablet compression. Recent product launches span high-complexity biologics and biosimilars — Bevacizumab biosimilar (Bevaris), Rituximab (Rituris), Tirzepatide pre-filled syringe (Wikijet), and Resmetirom (Livheal) — alongside a 2022-launched Herbal Division. The ophthalmic facility received EU GMP approval in 2025, and the company operates under WHO cGMP across all plants.

Revenue is generated through one-time prescription pharmaceutical product sales to domestic and international distributors, healthcare providers, and patients; pricing is not publicly disclosed. The company is founder/management-controlled, led by Chairman & Managing Director M. A. Hassan, with no disclosed institutional investors, funding rounds, or M&A activity.

Aristopharma firmographics

Firmographics
Name
Aristopharma
Legal name
Aristopharma Ltd
Website
https://aristopharma.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Aristopharma Ltd is a privately held top-10 Bangladeshi pharmaceutical manufacturer founded in 1986, producing ~300 brands across cardiovascular, diabetes, ophthalmic, oncology, and herbal therapeutics for domestic patients and exports to 30+ countries.
Ownership category
akta.pro rank

Aristopharma industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Generic pharmaceutical manufacturing
  • Ophthalmic medicines
  • Oncology therapeutics
  • Cardio-diabetic formulations
  • Biotech pharmaceuticals

Where Aristopharma is headquartered

Location

Headquarters

HQ city
Dhaka
HQ country
Bangladesh
HQ region
Asia

Offices3 records

Markets served

Aristopharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Manufacturing and selling quality medicines at affordable prices in Bangladesh and export markets. Products include pharmaceutical formulations across wide therapeutic classes including antiulcerants, antibiotics, NSAIDs, cardiovasculars, antidiabetics, steroids, and sophisticated products like Insulin, Inhalers, Anti-Cancer drugs, and biotech products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Aristopharma product offering

Product offering

Core offering

Aristopharma manufactures and sells approximately 300 pharmaceutical brands spanning multiple therapeutic classes including cardiovascular, antidiabetic, ophthalmic, oncology, gastroenterology, antibiotics, NSAIDs, respiratory, and herbal products. Operations are supported by two manufacturing plants in Bangladesh producing tablets, capsules, injectables, inhalers, ophthalmic solutions (including preservative-free single-unit dosages via Blow-Fill-Seal technology), lyophilized injections, pre-filled syringes, and biotech products such as Insulin and monoclonal antibodies (Bevacizumab, Rituximab).

Product overview

Aristopharma Ltd is a top 10 pharmaceutical company in Bangladesh manufacturing around 300 quality brands across diverse therapeutic classes. The portfolio includes cardiovascular products (Duoblock, Empaglif, Ivacard, Renvista, SabiCard), diabetes medications (Linaglip-M, Triflo, Wikijet, Wikitin), ophthalmic products (Optimox Eye Drop, Systear, Drylief, Taflan SUD, Cyporin DS, Cozopt SUD, Betaxol, Aristopin), gastroenterology medications (Rabe, Emep MUPS, Itopa-50, Vonofix, Sodipic), antibiotics (Afix, Lizox, Zavicef), oncology drugs (Bevaris, Rituris, Palbociclib), respiratory products (Asmalin Plus, Budison-FG, Montril, Docopa), orthopedic/pain management (Naburel, Joinflex-M, Adronic), and nutritional supplements (Fosibon-DK, Neobion, Tocogel, Cutin, Cozyten, Acufer, Ferijet). The company also has a dedicated herbal division and manufactures biotech products including insulin. Key manufacturing facilities include ophthalmic, cephalosporin, inhaler, lyophilized injection, and pre-filled syringe plants, with EU GMP approval for ophthalmic manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

  • Aristovision: Aristopharma's ophthalmic division that has completed its successful journey of 20 years in Bangladesh pharma market and has held the No. 1 position in the BD ophtha market since 2006.

Products and services

  • Pharma Products Wide range of branded generic pharmaceutical formulations including antiulcerants, antibiotics, NSAIDs, steroids, and other essential medicines manufactured at Aristopharma's plants in Shampur and Gachha, Gazipur. Targeted at physicians, hospitals, clinics, and pharmaceutical distributors in Bangladesh and 30+ export markets.
  • Ophthalmic Products (Aristovision) Dedicated ophthalmic division Aristovision manufacturing ocular lubricants, anti-infective eye drops, anti-glaucoma preparations, steroid combinations, and preservative-free single-unit-dosage formulations using Blow-Fill-Seal technology. EU GMP certified facility. Has held the No. 1 position in Bangladesh's ophthalmic market since 2006. Products include Systear, Drylief, Taflan SUD, Cyporin DS, Cozopt SUD, Optimox, Betaxol, Aristopin, and Dexalev.
  • Cardio-Diabetic Products Cardiovascular and antidiabetic branded formulations including SGLT2 inhibitors (Empaglif), DPP-4 inhibitors (Linaglip-M, Wikitin), dual GLP-1/GIP analogues (Wikijet), fixed-dose combinations (Duoblock, Temcard-A, Empaglif-M), sacubitril/valsartan (SabiCard), ivabradine (Ivacard), and resmetirom (Livheal) for NASH/MASH. Targeted at cardiologists, diabetologists, and endocrinology specialists.
  • Oncology Products Anti-cancer biologics and chemotherapeutics including biosimilar monoclonal antibodies Bevacizumab (Bevaris) for various cancers, Rituximab (Rituris) for Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis, and zoledronic acid (Adronic 4) for osteoporosis. Manufactured in dedicated oncology plant within the Gachha, Gazipur campus.
  • Herbal Products Dedicated herbal product range manufactured at a WHO-cGMP compliant herbal plant within the Gazipur factory campus, including Fibosyl Powder, Arulina-500 (Spirulina), Hepamarin-140 (Silymarin), Joinflex-40, Anseng-500 (Panax ginseng), Ginkgo-B 60, and Primrole. Also encompasses Black Seed Oil (Blaksid) softgel and herbal cough formulations like Ivycof and Pepelif.
  • Biotech Products Biopharmaceutical products including Insulin, monoclonal antibody biosimilars (Bevacizumab, Rituximab), and pre-filled syringe injectables manufactured at a dedicated biotech facility in the Gazipur plant. Targeted at hospitals, oncology centers, and patients requiring advanced biologic therapies.

Quantifiable outcome

  • No.1 market position in Bangladesh ophthalmic market since 2006
  • +2 more outcomes

Companies that use Aristopharma

Customer profile

Segments3 records

Ideal customer profiles3 records

Aristopharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Aristopharma partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Aristopharma competitors and assessment

Company assessment

Direct peers

  • Incepta Pharmaceuticals: One of the fastest-growing Bangladesh pharma manufacturers, focused on specialty generics, biotech, and export markets. Competes directly with Aristopharma in cardiology, oncology, and biotech.
  • Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer. Same product categories (cardio, diabetic, oncology, ophthalmic, biotech), same domestic distribution dynamics, and similar export ambitions — the most direct comparable to Aristopharma.
  • Healthcare Pharmaceuticals: Bangladesh pharma manufacturer with growing focus on specialty care, oncology, and biotech. Comparable in product mix and export ambitions to Aristopharma.
  • Renata Limited: Bangladesh's leading animal health and specialty pharmaceutical company, with a strong domestic and emerging export footprint. Comparable in therapeutic breadth and Bangladesh market positioning.
  • Beximco Pharmaceuticals: Top-3 Bangladesh pharma player with strong export presence and a broad specialty/generic portfolio, including biosimilars. Comparable in scale, therapeutic breadth, and export strategy to Aristopharma.
  • ACI Limited (Pharma Division): Diversified Bangladeshi conglomerate with a sizable pharma division spanning branded generics, specialty care, and biotech. Overlaps with Aristopharma across most therapeutic categories and competes in the same domestic market.
  • Drug International Limited: Bangladesh-based pharmaceutical company manufacturing generics and specialty products, including ophthalmics. Competes directly with Aristopharma in Bangladesh's domestic market.

Broad incumbents

  • Dr. Reddy's Laboratories: Large Indian generic and specialty pharma player with global operations including biosimilars. Comparable therapeutic breadth and export footprint — relevant incumbent benchmark for Aristopharma's expansion ambitions.
  • Cipla: Major Indian pharma with strong respiratory, oncology, and specialty portfolios and a sizable emerging-markets presence. Useful comparable for Aristopharma's inhaler/respiratory and specialty aspirations.
  • Sun Pharmaceutical Industries: India's largest specialty pharma company with a strong ophthalmology franchise. Closest large-cap analog to Aristopharma's specialty-generic and ophthalmic-led strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Aristopharma social profiles

Digital presence

Aristopharma compliance and trust

Trust signal

Compliance3 records

Aristopharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aristopharma leadership team

Management profile

Number of profiles

Profiles3 records

Aristopharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aristopharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aristopharma

What does Aristopharma do?

Aristopharma manufactures and sells approximately 300 pharmaceutical brands spanning multiple therapeutic classes including cardiovascular, antidiabetic, ophthalmic, oncology, gastroenterology, antibiotics, NSAIDs, respiratory, and herbal products. Operations are supported by two manufacturing plants in Bangladesh producing tablets, capsules, injectables, inhalers, ophthalmic solutions (including preservative-free single-unit dosages via Blow-Fill-Seal technology), lyophilized injections, pre-filled syringes, and biotech products such as Insulin and monoclonal antibodies (Bevacizumab, Rituximab).

Is Aristopharma a public or private company?

Aristopharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Aristopharma founded?

Aristopharma was founded in 1986. It employs 501 to 1,000 people.

Where is Aristopharma based?

Aristopharma is headquartered in Dhaka, Bangladesh, in the Asia region.

How does Aristopharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Aristopharma's main competitors?

Direct peers on record are Incepta Pharmaceuticals, Square Pharmaceuticals, Healthcare Pharmaceuticals, Renata Limited, Beximco Pharmaceuticals, ACI Limited (Pharma Division) and Drug International Limited. Broad incumbents are Dr. Reddy's Laboratories, Cipla and Sun Pharmaceutical Industries.

Does Aristopharma have an API?

No public API is recorded for Aristopharma.

What industry is Aristopharma in?

Aristopharma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales